Press
Press Release-News
- PRESS RELEASE: PARIS april 12, 2010: BMSystems is selected by French life science clusters to present its disruptive science & business model during BiO in Chicago.
- PRESS RELEASE: PARIS march 11, 2010: BMSystems is invited to present at 2 international scientific conferences. These 2 invitations confirm the major contributions of BMSystems to the field of integrative systems biology.
- PRESS RELEASE: PARIS February
3, 2010:
Pherecydes Pharma, BMSystems' spin-off, is becoming a US reference in the field of biosecurity and biodefense and a credible partner for protein, antibody & enzyme improvements.
- NEWS: January 20, 2010: Strategic Partner News: ARD, leader of our "Synthons" Industrial Biotech program, announced the successful start-up and commissioning of the world’s first renewable succinic acid plant with an initial annual capacity of 2,000 metric tons.
- PRESS RELEASE: Paris October 14, 2009: Pherecydes-Pharma, the world's first biotech company created from an integrative biology research program gears up for business development.
- PRESS RELEASE: July 28, 2009 BMSystems receives a Bio-IT World Best Practices Award from the Cambridge Healthtech Institute.
- PRESS RELEASE: BMSystems, BioXpr and Kayentis launch BioXplain at BiO Atlanta the First Open Platform for Iterative, Predictive and Integrative Biology
- PRESS RELEASE: Paris, October 6, 2008. Biocitech, the Paris life science park welcomes Pherecydes Pharma, BMSystems' spin-off, the first biodefense and biosecurity company in France
- NEWS: Paris September 25, 2008 : The utilization of CADI™ (BMSystems' biological modeling approach and technologies) leads to a new industrial success in CNS diseases. BMSystems filed on Septembers 10, 2008, with CEA life Sciences, a patent application covering new therapeutic strategies and a preclinical evaluation platform in the field of psychiatric disorders.
- NEWS: Paris, January 26, 2008: We were very happy to announce the future publication of " Biological modeling in the discovery and validation of cognitive dysfunctions biomarkers" in a book edited by the Max Planck Institute for Psychiatry in Munich, highlighting the impact of our biological modeling capacities upon research progress in the field of cognitive dysfunctions. Publication in November 2008
- NEWS: Paris December 20, 2006: BMSystems is very happy to announce the successful launch of our first company spin-off in the field of Bio-Defense and Bio-Security developed from our CADI discovery process. Pherecydes Pharma S.A. (anti-bacterial bio-agents) was incorporated on December 20, 2006
- PRESS-RELEASE: July 28, 2006: The " Synthons" program, the major white biotech R& D program of the I.A.R. (" Industrie Agro-Ressources" world class white biotech cluster in France), was selected for state grants. BMSystems is the biotech leading partner of the " Synthons" program
- PRESS-RELEASE: Paris May 23, 2006: Download Beyond Genome BMSystems press release
- PRESS-RELEASE: Paris July 18, 2005: Analytical Methods for Metabolic Profiling: Solving Problems Analysis" release
- PRESS-RELEASE: Paris March 29, 2005: Bio-Modeling Systems published its second in-silico model " Model of Therapeutic Resistance to Tamoxifen" in the Journal of Molecular Endocrinology
- PRESS-RELEASE: Paris January 15, 2004: A world’s first: Ras-dependent breast Cancer model. The first model on a complex human disease was published in the October 2003 issue of Nucleic Acids Research (Oxford University Press). Integrative Biology produces its first bio-medical results and confirms its ability to really deliver
Press articles
- 2006:BioCentury (English). February, 13 2006. Article on BMSystems CADI technologies
- 2006: Biotech info Letter (English). June 2-6, 2006 Atlanta Georgia: ASCO congress . Dr François Iris interview about our Cancer CADI models
- 2005: Les Echos December 7, 2005 page 29 (French): CEO article: A militant for the development of biotech
- 2005: La Recherche revue (French) February 2005 Systems biology : The industrial challenge
- 2004: Revue ECRIN n°54 January 2004 (French): Pharma industry becomes seriously interested in integrative biology,
- 2003: Biotech Info n°203 November 2003, page 8 (French): Integrative biology, is currently contractually collaborating with Big Pharma in major domains of drugs and targets therapeutic applications
- 2003: Revue ECRIN n°52 May 2003 (French). Integrative biology presented at a biotech-Pharma meeting
- 2003: Biotech Info n°173 March 2003, page 4-5 (French) : Integrative biology, applications on this innovative approach
BMSystems: a leading Systems Biology / Integrative Biology company that delivers
Copyright © 2010 Bio-Modeling Systems / bioModeling Systems / BMSystems. All rights reserved bmsystems(at)bmsystems.net or biomodeling(at)bmsystems.net
Copyright © 2010 Bio-Modeling Systems / bioModeling Systems / BMSystems. All rights reserved bmsystems(at)bmsystems.net or biomodeling(at)bmsystems.net